Key Takeaways
- • Harvard's endowment delivered a 9.6% return in fiscal year 2024, growing to $53.2 billion and marking the first year of growth since fiscal 2021, though this ranked third among Ivy+ peers—trailing Yale and Princeton despite the overall positive performance.
- • Long-term underperformance persists: Harvard's cumulative return between 2020 and 2024 averaged 10.3%, lagging the Ivy League average of 11% and falling short of the S&P 500 benchmark, raising questions about the sustainability of CEO N.P. "Narv" Narvekar's 2017 strategic overhaul.
- • Narvekar's five-year restructuring plan shifted Harvard Management Company away from traditional internal management toward external management via hedge funds and private equity, a pivot designed to boost returns but whose long-term efficacy remains contested among financial experts.
- • Academic experts caution against single-year performance evaluation, with Princeton economist W. Bentley MacLeod warning that yearly returns obscure structural trends—comparing the metric to "weather versus climate" in assessing endowment health.
- • Harvard's 39% allocation to private equity remains below peer allocations, suggesting potential exposure gaps or deliberate risk management that may be constraining relative returns compared to competitors.
Summary
The broader picture reveals structural challenges. Between 2020 and 2024, Harvard's endowment returned 10.3% cumulatively—trailing the Ivy League average of 11% and underperforming the S&P 500 benchmark. Peer institutions, particularly Yale and Princeton, reported returns that merely tracked inflation in fiscal 2024, yet their multi-year performance trajectories remain superior to Harvard's. This dynamic suggests that Harvard's improved 2024 showing may represent cyclical recovery rather than strategic vindication.
Narvekar assumed leadership of Harvard Management Company in 2017 and implemented a comprehensive restructuring strategy that dismantled the institution's traditional internal management apparatus in favor of external management through hedge funds and private equity firms. The strategic rationale centered on performance enhancement, yet long-term results have failed to deliver the relative outperformance the endowment had historically achieved. Harvard's current 39% allocation to private equity sits below comparable allocations at peer institutions, potentially indicating either deliberate risk calibration or an exposure gap affecting relative returns.
Financial experts and academic analysts have cautioned against over-interpreting annual performance metrics. W. Bentley MacLeod, professor of economics at Princeton University, emphasized that "one should never evaluate endowments based upon yearly return," comparing the analytical error to conflating weather with climate. The distinction is material: near-term recovery cycles can mask deteriorating structural performance and strategy effectiveness. For Harvard—whose endowment is the largest in the Ivy League—this gap between annual performance and multi-year trends carries significant implications for future capital allocation and operational funding, as the endowment distributed $2.5 billion during fiscal 2025 to support University operations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.